Literature DB >> 31831844

NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemia.

Atom J Wang1,2, Youqi Han1, Nanyang Jia3, Peikun Chen3, Mark D Minden4,5.   

Abstract

Normal cytogenetic acute myeloid leukemia (AML) frequently harbor a TCTG insertion in exon 12 of Nucleophosmin 1 (NPM1); the resulting frameshift creates a nuclear export signal (NES) and cytoplasmic localization of NPM1c. However, how NPM1c causes AML is not completely understood. NPM1 participates in multiple protein-protein interactions one of which involves the CCCTC-binding factor (CTCF). Through binding of CTCF binding sites (CBS), CTCF mediates nuclear functions including DNA looping, regulation of gene expression, and RNA splicing. We hypothesized that mislocalization of CTCF into the cytoplasm by NPM1c reduces the functional level of nuclear CTCF and so alters gene expression. We verified the interaction of CTCF with NPM1 and showed that CTCF interacts with NPM1c, with redistribution of CTCF into the cytoplasm. The interaction of CTCF and NPM1c involves the amino terminus of CTCF and the last 50 amino acids of NPM1. By interfering with the interaction of CTCF and NPM1c, CTCF becomes relocalized into the nucleus.

Entities:  

Year:  2019        PMID: 31831844     DOI: 10.1038/s41375-019-0681-8

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

Review 1.  SubCellBarCode: integrated workflow for robust spatial proteomics by mass spectrometry.

Authors:  Taner Arslan; Yanbo Pan; Georgios Mermelekas; Mattias Vesterlund; Lukas M Orre; Janne Lehtiö
Journal:  Nat Protoc       Date:  2022-06-22       Impact factor: 17.021

Review 2.  Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors.

Authors:  Daisuke Ikeda; SungGi Chi; Satoshi Uchiyama; Hirotaka Nakamura; Yong-Mei Guo; Nobuhiko Yamauchi; Junichiro Yuda; Yosuke Minami
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

Review 3.  CTCF-mediated genome organization and leukemogenesis.

Authors:  Yi Qiu; Suming Huang
Journal:  Leukemia       Date:  2020-06-09       Impact factor: 11.528

4.  Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.

Authors:  Meixi Peng; Jun Ren; Yipei Jing; Xueke Jiang; Qiaoling Xiao; Junpeng Huang; Yonghong Tao; Li Lei; Xin Wang; Zailin Yang; Zesong Yang; Qian Zhan; Can Lin; Guoxiang Jin; Xian Zhang; Ling Zhang
Journal:  J Extracell Vesicles       Date:  2021-11

Review 5.  Advances in molecular characterization of myeloid proliferations associated with Down syndrome.

Authors:  Jixia Li; Maggie L Kalev-Zylinska
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

Review 6.  Determinants and role of chromatin organization in acute leukemia.

Authors:  Celestia Fang; Sridhar Rao; John D Crispino; Panagiotis Ntziachristos
Journal:  Leukemia       Date:  2020-07-20       Impact factor: 11.528

7.  Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells.

Authors:  Reza Ghasemi; Heidi Struthers; Elisabeth R Wilson; David H Spencer
Journal:  Leukemia       Date:  2020-05-12       Impact factor: 11.528

Review 8.  A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML.

Authors:  Katelyn E Heimbruch; Alison E Meyer; Puja Agrawal; Aaron D Viny; Sridhar Rao
Journal:  Neoplasia       Date:  2021-02-20       Impact factor: 5.715

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.